Edition:
United Kingdom

Denali Therapeutics Inc (DNLI.OQ)

DNLI.OQ on NASDAQ Stock Exchange Global Select Market

21.48USD
22 Feb 2019
Change (% chg)

$0.67 (+3.22%)
Prev Close
$20.81
Open
$20.98
Day's High
$21.69
Day's Low
$20.62
Volume
105,680
Avg. Vol
136,090
52-wk High
$23.34
52-wk Low
$12.36

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 1.20 -0.378
Jun '18 1.65 -0.589
Mar '18 0.64 -0.264
FY 2017 Dec '17 0.00 -0.223
Sep '17 0.00 -0.265
Jun '17 0.00 -2.289
Mar '17 0.00 -2.364
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 3 2.70 5.45 0.64 --
Quarter Ending Jun-19 3 3.04 5.45 1.65 --
Year Ending Dec-19 6 24.92 115.00 0.00 78.75
Earnings (per share)
Quarter Ending Mar-19 3 -0.43 -0.40 -0.47 --
Quarter Ending Jun-19 3 -0.44 -0.43 -0.45 --
Year Ending Dec-19 6 -1.69 -0.85 -2.03 -0.81
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta -- 1.08 0.90
Price to Sales (TTM) -- 49.51 6.29
Price to Book (MRQ) -- 10.14 5.26
Price to Tangible Book (MRQ) -- 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions -- 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.16 12.76
Sales (TTM) vs TTM 1 Yr. Ago -- 48.79 5.84
Sales - 5 Yr. Growth Rate -- 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate -- 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) -- 3.50 3.08
LT Debt to Equity (MRQ) -- 18.65 11.38
Total Debt to Equity (MRQ) -- 31.33 16.12
Interest Coverage (TTM) -- -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.41 12.87
Operating Margin (TTM) -- -184.63 6.19
Operating Margin - 5 Yr. Avg. -- -126.89 8.31
Pre-Tax Margin (TTM) -- -175.33 7.15
Pre-Tax Margin - 5 Yr. Avg. -- -132.69 8.61
Net Profit Margin (TTM) -- -182.03 3.29
Net Profit Margin - 5 Yr. Avg. -- -137.08 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,654,547 842,388,263
Net Income/Employee (TTM) -- 562,105 99,841,601
Receivable Turnover (TTM) -- 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) -- 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.39 11.06
Return on Assets - 5 Yr. Avg. -- 5.47 12.20
Return on Investment (TTM) -- 8.92 14.45
Return on Investment - 5 Yr. Avg. -- 6.78 15.87
Return on Equity (TTM) -- 10.08 15.96
Return on Equity - 5 Yr. Avg. -- 8.32 17.00

Performance for Denali Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 99
13 Week -- -- -- 95
26 Week -- -- -- 98
52 Week -- -- -- 72
YTD -- -- -- 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 84.55%
# of Holders: 136
Total Shares Held: 80,282,961
3 Mo. Net Change: 1,207,151
# New Positions: 26
# Closed Positions: 14
# Increased Positions: 78
# Reduced Positions: 44
# Net Buyers: 34
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.